WYAMYCIN S Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Wyamycin S, and when can generic versions of Wyamycin S launch?
Wyamycin S is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in WYAMYCIN S is erythromycin stearate. There are one hundred and three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for WYAMYCIN S
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | WYAMYCIN S at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for WYAMYCIN S
US Patents and Regulatory Information for WYAMYCIN S
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | WYAMYCIN S | erythromycin stearate | TABLET;ORAL | 061675-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | WYAMYCIN S | erythromycin stearate | TABLET;ORAL | 061675-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |